DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,078,890 | +9.2% | 76,900 | +5.6% | 0.30% | +10.4% |
| Q2 2023 | $17,476,320 | +11.2% | 72,818 | +16.8% | 0.27% | -5.3% |
| Q1 2023 | $15,713,434 | -15.0% | 62,345 | -10.5% | 0.28% | -24.5% |
| Q4 2022 | $18,485,972 | +3.9% | 69,648 | +1.1% | 0.38% | -7.6% |
| Q3 2022 | $17,792,000 | +6.3% | 68,884 | +4.3% | 0.41% | +1.0% |
| Q2 2022 | $16,743,000 | -13.3% | 66,041 | +0.3% | 0.40% | -2.0% |
| Q1 2022 | $19,310,000 | -5.0% | 65,831 | +6.6% | 0.41% | -3.3% |
| Q4 2021 | $20,324,000 | +59.4% | 61,776 | +47.5% | 0.42% | +40.4% |
| Q3 2021 | $12,749,000 | +12.6% | 41,880 | -0.8% | 0.30% | +12.3% |
| Q2 2021 | $11,325,000 | +1.3% | 42,203 | -15.0% | 0.27% | -8.2% |
| Q1 2021 | $11,180,000 | -3.9% | 49,672 | -5.2% | 0.29% | -11.5% |
| Q4 2020 | $11,639,000 | +2.9% | 52,397 | -0.2% | 0.33% | -7.5% |
| Q3 2020 | $11,306,000 | +26.3% | 52,506 | +3.7% | 0.36% | +15.9% |
| Q2 2020 | $8,952,000 | +24.7% | 50,626 | -2.4% | 0.31% | +4.7% |
| Q1 2020 | $7,178,000 | -6.6% | 51,861 | +3.5% | 0.30% | +13.5% |
| Q4 2019 | $7,688,000 | +3.5% | 50,093 | -2.6% | 0.26% | -6.1% |
| Q3 2019 | $7,429,000 | +14.8% | 51,440 | +13.6% | 0.28% | +6.1% |
| Q2 2019 | $6,474,000 | -15.9% | 45,299 | -22.3% | 0.26% | +105.5% |
| Q1 2019 | $7,698,000 | +45.2% | 58,313 | +13.4% | 0.13% | +32.3% |
| Q4 2018 | $5,301,000 | -14.8% | 51,413 | -10.2% | 0.10% | 0.0% |
| Q3 2018 | $6,220,000 | +11.9% | 57,244 | +1.6% | 0.10% | +12.9% |
| Q2 2018 | $5,559,000 | +1.9% | 56,335 | +1.1% | 0.08% | +4.9% |
| Q1 2018 | $5,453,000 | +2.9% | 55,699 | -2.4% | 0.08% | +2.5% |
| Q4 2017 | $5,299,000 | -4.7% | 57,089 | -11.9% | 0.08% | -9.2% |
| Q3 2017 | $5,561,000 | -0.7% | 64,834 | -2.3% | 0.09% | -4.4% |
| Q2 2017 | $5,602,000 | +26.3% | 66,387 | +28.0% | 0.09% | +21.3% |
| Q1 2017 | $4,434,000 | +21.5% | 51,847 | +10.6% | 0.08% | +7.1% |
| Q4 2016 | $3,650,000 | -1.2% | 46,894 | -0.5% | 0.07% | -12.5% |
| Q3 2016 | $3,693,000 | -22.6% | 47,119 | -0.2% | 0.08% | -44.8% |
| Q2 2016 | $4,769,000 | +8.3% | 47,227 | +1.7% | 0.14% | +6.6% |
| Q1 2016 | $4,405,000 | +6.6% | 46,437 | +4.3% | 0.14% | -2.2% |
| Q4 2015 | $4,133,000 | +3.8% | 44,505 | -4.8% | 0.14% | +2.2% |
| Q3 2015 | $3,982,000 | -3.8% | 46,743 | -3.4% | 0.14% | +3.8% |
| Q2 2015 | $4,139,000 | -2.5% | 48,364 | -3.3% | 0.13% | +1.6% |
| Q1 2015 | $4,244,000 | -8.2% | 49,995 | -7.3% | 0.13% | -9.2% |
| Q4 2014 | $4,621,000 | +3.5% | 53,922 | -8.3% | 0.14% | +3.6% |
| Q3 2014 | $4,465,000 | -13.0% | 58,772 | -9.8% | 0.14% | -6.2% |
| Q2 2014 | $5,130,000 | -51.5% | 65,160 | -53.8% | 0.15% | -53.2% |
| Q1 2014 | $10,575,000 | -4.7% | 141,009 | -1.9% | 0.31% | -2.5% |
| Q4 2013 | $11,097,000 | +7.7% | 143,753 | -3.3% | 0.32% | +8.5% |
| Q3 2013 | $10,305,000 | +5.6% | 148,659 | -3.6% | 0.30% | +7.3% |
| Q2 2013 | $9,758,000 | – | 154,163 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |